Menopause Hormone Therapy (HRT) in Concord, NH

Bioidentical hormones in Concord: what it means

"Bioidentical" is a word compounding pharmacies often use in marketing, but what it describes is real: a hormone built like the body's own. Two hormones used in menopause care fit it exactly, estradiol and micronized progesterone. Neither has to be compounded: FDA-approved estradiol comes as pills, patches, gels, sprays, vaginal creams and rings, and progesterone as capsules.

Many products sold as "bioidentical hormones" or "BHRT" are compounded instead: mixed by a pharmacy for one prescription, often as a custom cream or a pellet. They are not FDA-approved, which means the FDA cannot assure their safety or effectiveness. The FDA also says it has no evidence that they are safe and effective, or more effective than approved hormone therapy. The National Academies, reviewing them for the FDA in 2020, called their wide use a public health concern.

Concord is a center for OB-GYN care: the federal NPI registry lists 27 OB-GYNs with a primary practice address in the city, 61.1 per 100,000 residents, 3.4 times the US rate of 17.8 and above New Hampshire's 21.0. That is more per resident than 90% of the 924 cities VevaMD covers. Set against the city's 5,568 women aged 45 to 64, that is one OB-GYN for roughly every 210.

Within 10 miles of the city there are 27 OB-GYNs, and within 25 miles 97, about 21.6 per 100,000 of the 449,326 residents in that radius. Whether or not you have an OB-GYN, you can ask a physician licensed in New Hampshire about menopause hormone therapy online from Concord, with no waiting room.

You do not choose a "bioidentical" product from a menu: after a private intake, a physician licensed in New Hampshire decides what, if anything, fits, and the form. Pellets are not part of it. Since the pharmacy that fills these prescriptions also compounds, ask whether yours is an FDA-approved product or compounded. Testosterone cream for women and Bi-Est are compounded and not FDA-approved.

A pellet clinic is a different model: it implants a hormone pellet under the skin during a visit, and compounded pellets are not FDA-approved. The Endocrine Society cites blood levels well above the expected range in women using compounded pellets. ACOG's guidance is to prefer FDA-approved menopause hormone therapy to compounded hormones.

Sources: FDA: Menopause · FDA: National Academies study of compounded bioidentical hormones (2020) · Endocrine Society position statement on compounded bioidentical hormones (2019) · ACOG Clinical Consensus No. 6, compounded bioidentical menopausal hormone therapy (2023) · CMS NPPES NPI full file, 2026-10-11